Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes

Pulmonary artery hypertension (PAH) is very rare in childhood, and it can be divided into heritable, idiopathic drug- and toxin-induced and other disease (connective tissue disease, human immunodeficiency virus infection, portal hypertension, congenital heart disease, or schistosomiasis)-associated...

Full description

Bibliographic Details
Main Author: Shi-Min Yuan
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Pediatrics and Neonatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957217304862
_version_ 1826574855347109888
author Shi-Min Yuan
author_facet Shi-Min Yuan
author_sort Shi-Min Yuan
collection DOAJ
description Pulmonary artery hypertension (PAH) is very rare in childhood, and it can be divided into heritable, idiopathic drug- and toxin-induced and other disease (connective tissue disease, human immunodeficiency virus infection, portal hypertension, congenital heart disease, or schistosomiasis)-associated types. PAH could not be interpreted solely by pathophysiological theories. The impact of the transforming growth factor-β superfamily-related genes on the development of PAH in children remains to be clarified. Pertinent literature on the transforming growth factor-β superfamily-related genes in relation to PAH in children published after the year 2000 was reviewed and analyzed. Bone morphogenetic protein receptor type II gene mutation promotes cell division or prevents cell death, resulting in an overgrowth of cells in small arteries throughout the lungs. About 20% of individuals with a bone morphogenetic protein receptor type II gene mutation develop symptomatic PAH. In heritable PAH, bone morphogenetic protein receptor type II mutations may be absent; while mutations of other genes, such as type I receptor activin receptor-like kinase 1 and the type III receptor endoglin (both associated with hereditary hemorrhagic telangiectasia), caveolin-1 and KCNK3, the gene encoding potassium channel subfamily K, member 3, can be detected, instead. Gene mutations, environmental changes and acquired adjustment, etc. may explain the development of PAH. The researches on PAH rat model and familial PAH members may facilitate the elucidations of the mechanisms and further provide theories for prophylaxis and treatment of PAH. Key Words: bone morphogenetic proteins, mutation, pulmonary hypertension
first_indexed 2024-12-21T18:26:30Z
format Article
id doaj.art-c09e19d1c9614a5d8965ebb0dcfa3432
institution Directory Open Access Journal
issn 1875-9572
language English
last_indexed 2025-03-14T13:05:26Z
publishDate 2018-04-01
publisher Elsevier
record_format Article
series Pediatrics and Neonatology
spelling doaj.art-c09e19d1c9614a5d8965ebb0dcfa34322025-03-02T01:43:17ZengElsevierPediatrics and Neonatology1875-95722018-04-01592112119Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genesShi-Min Yuan0Department of Cardiothoracic Surgery, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, 389 Longdejing Street, Chengxiang District, Putian 351100, Fujian Province, People's Republic of China.; Department of Cardiothoracic Surgery, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of ChinaPulmonary artery hypertension (PAH) is very rare in childhood, and it can be divided into heritable, idiopathic drug- and toxin-induced and other disease (connective tissue disease, human immunodeficiency virus infection, portal hypertension, congenital heart disease, or schistosomiasis)-associated types. PAH could not be interpreted solely by pathophysiological theories. The impact of the transforming growth factor-β superfamily-related genes on the development of PAH in children remains to be clarified. Pertinent literature on the transforming growth factor-β superfamily-related genes in relation to PAH in children published after the year 2000 was reviewed and analyzed. Bone morphogenetic protein receptor type II gene mutation promotes cell division or prevents cell death, resulting in an overgrowth of cells in small arteries throughout the lungs. About 20% of individuals with a bone morphogenetic protein receptor type II gene mutation develop symptomatic PAH. In heritable PAH, bone morphogenetic protein receptor type II mutations may be absent; while mutations of other genes, such as type I receptor activin receptor-like kinase 1 and the type III receptor endoglin (both associated with hereditary hemorrhagic telangiectasia), caveolin-1 and KCNK3, the gene encoding potassium channel subfamily K, member 3, can be detected, instead. Gene mutations, environmental changes and acquired adjustment, etc. may explain the development of PAH. The researches on PAH rat model and familial PAH members may facilitate the elucidations of the mechanisms and further provide theories for prophylaxis and treatment of PAH. Key Words: bone morphogenetic proteins, mutation, pulmonary hypertensionhttp://www.sciencedirect.com/science/article/pii/S1875957217304862
spellingShingle Shi-Min Yuan
Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
Pediatrics and Neonatology
title Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
title_full Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
title_fullStr Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
title_full_unstemmed Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
title_short Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes
title_sort pulmonary artery hypertension in childhood the transforming growth factor β superfamily related genes
url http://www.sciencedirect.com/science/article/pii/S1875957217304862
work_keys_str_mv AT shiminyuan pulmonaryarteryhypertensioninchildhoodthetransforminggrowthfactorbsuperfamilyrelatedgenes